These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12692417)

  • 21. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
    Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
    Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR; Luo JY; Shang L; Kong WM
    Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study.
    Boyer J; Saint-Paul MC; Dadone B; Patouraux S; Vivinus MH; Ouvrier D; Michiels JF; Piche T; Tulic MK
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28975689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal mast cells in irritable bowel syndrome and inflammatory bowel disease.
    Tunc B; Filik L; Altintaş E; Turhan N; Ulker A; Dağli U
    Acta Medica (Hradec Kralove); 2005; 48(3-4):163-4. PubMed ID: 16640031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological alterations in post-infectious irritable bowel syndrome in Bangladeshi population.
    Bhuiyan MR; Majumder TK; Raihan AA; Roy PK; Farha N; Kamal M
    Mymensingh Med J; 2010 Apr; 19(2):275-81. PubMed ID: 20395926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?
    İliaz R; Akyüz F; Yeğen G; Örmeci A; Göktürk S; Akyüz Ü; Baran B; Mutluay Ö; Evirgen S; Karaca Ç; Demir K; Beşışık F; Güllüoğlu M; Kaymakoğlu S
    Turk J Gastroenterol; 2018 Jul; 29(4):384-391. PubMed ID: 30249551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mast cells in the irritable bowel syndrome.
    O'Sullivan M; Clayton N; Breslin NP; Harman I; Bountra C; McLaren A; O'Morain CA
    Neurogastroenterol Motil; 2000 Oct; 12(5):449-57. PubMed ID: 11012945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
    Hughes PA; Harrington AM; Castro J; Liebregts T; Adam B; Grasby DJ; Isaacs NJ; Maldeniya L; Martin CM; Persson J; Andrews JM; Holtmann G; Blackshaw LA; Brierley SM
    Gut; 2013 Oct; 62(10):1456-65. PubMed ID: 22767422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity.
    van Hoboken EA; Thijssen AY; Verhaaren R; van der Veek PP; Prins FA; Verspaget HW; Masclee AA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):981-7. PubMed ID: 21623672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
    Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast Cells in Irritable Bowel Syndrome: A Systematic Review.
    Krammer L; Sowa AS; Lorentz A
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):463-472. PubMed ID: 31826052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic overlap in patients with diarrhea predominant irritable bowel syndrome and microscopic colitis in a sub group of Bangladeshi population.
    Rahman MA; Raihan AS; Ahamed DS; Masud H; Safiullah AB; Khair KB; Salimullah AS; Islam MM
    Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):33-8. PubMed ID: 22545349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome.
    Dunlop SP; Jenkins D; Spiller RC
    Am J Gastroenterol; 2003 Jul; 98(7):1578-83. PubMed ID: 12873581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Hasler WL; Grabauskas G; Singh P; Owyang C
    Neurogastroenterol Motil; 2022 Jul; 34(7):e14339. PubMed ID: 35315179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
    Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
    Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.